Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system

1998 ◽  
Vol 96 (2) ◽  
pp. 157-162 ◽  
Author(s):  
M. Deckert-Schlüter ◽  
Andrea Rang ◽  
Otmar D. Wiestler
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Gene Products ◽  
Related Gene ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The Central Nervous System ◽  
Apoptosis Related Gene

Primary T Cell Non-Hodgkin’s Lymphoma of the Central Nervous System

1994 ◽  
Vol 91 (3) ◽  
pp. 158-163 ◽  
Author(s):  
Sadaya Matano ◽  
Shinobu Nakamura ◽  
Shigeki Ohtake ◽  
Hirokazu Okumura ◽  
Yoko Okabe ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
T Cell ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The Central Nervous System

Non Hodgkin's lymphoma involving the adrenal glands and the central nervous system (CNS): a particular evolution after chemotherapy

2005 ◽  
Vol 66 (6) ◽  
pp. 527-531 ◽  
Author(s):  
F.-L. Vélayoudom ◽  
C. Cardot-Bauters ◽  
A.-V. Decouvelaere ◽  
V. Vlaeminck ◽  
F. Bauters ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Hodgkin’S Lymphoma ◽  
Adrenal Glands ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The Central Nervous System

scholarly journals Multicentric Involvement of Non-Hodgkin's Lymphoma in the Central Nervous System and Testis-Case Report-

2004 ◽  
Vol 44 (9) ◽  
pp. 493-496
Author(s):  
Kenichiro ONO ◽  
Hirohiko ARIMOTO ◽  
Kojiro WADA ◽  
Takashi TAKAHARA ◽  
Toshiki SHIROTANI ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The Central Nervous System

scholarly journals Primary testicular non-Hodgkin's lymphoma: a review article

2007 ◽  
Vol 125 (5) ◽  
pp. 286-288 ◽  
Author(s):  
Komal Bhatia ◽  
Ashok Kumar Vaid ◽  
Sachin Gupta ◽  
Dinesh Chandra Doval ◽  
Vineet Talwar
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Hodgkin’S Lymphoma ◽  
Testicular Tumor ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Stage Disease ◽  
Non Hodgkin's Lymphoma ◽  
High Incidence ◽  
The Central Nervous System

Primary testicular non-Hodgkin's lymphoma was first described as a clinical entity in 1866. It is a rare disease and accounts for 1% of all non-Hodgkin's lymphoma, 2% of all extranodal lymphomas and 5% of all testicular neoplasms. It is the most common testicular tumor in males between sixty and eighty years of age. Testicular non-Hodgkin's lymphoma is unique in its high incidence of bilateral involvement (8-38%), and it is also the most common bilateral testicular tumor. Testicular non-Hodgkin's lymphoma has a predilection for spreading to non-contiguous extranodal sites, especially the central nervous system. Advanced-stage disease is usually managed with doxorubicin-based chemotherapy. For early-stage disease, opinion is divided regarding systemic chemotherapy following orchidectomy. The high incidence of spreading, especially to the central nervous system, leads to advocacy of the use of central nervous system prophylaxis with intrathecal chemotherapy. Prospective multicenter trials incorporating a large number of patients may lead to better guidelines for optimal management of this subtype of non-Hodgkin's lymphoma.

Sign in / Sign up

Export Citation Format

Share Document